SME1: Regulatory updates for SMEs, academia and start-ups
By Margareth Jorvid2025-11-18T09:59:00
Key points:
- Small and medium-sized enterprises (SMEs), academia and start-ups meet different regulatory challenges when developing the life science products of the future to meet patients’ needs
- The session speakers gave information on what support is available from the European Medicines Agency (EMA) and the Paul-Ehrlich-Institut (PEI), along with practical examples and experience from Actimed as an SME
To read more key points and the session summary, login as a member or register for free using the links below.